Medication
|
Benefit Category
|
Details
|
Link
|
| Abilify (aripiprazole) |
Open benefit |
............................................................. |
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Abilify Maintena (aripiprazole LAI) |
Special Authorization |
For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients:
• who are non-adherent to an oral antipsychotic. OR • who are currently receiving a long-acting injectable antipsychotic and require a switch to another injectable. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02420864&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=aripiprazole |
| Clozaril (clozapine) |
Special Authorization |
For patients diagnosed with treatment resistant schizophrenia who have not obtained a satisfactory clinical response, despite treatment with appropriate courses of maximum tolerated* therapeutic doses, of at least two chemically unrelated anti-psychotic medications. *intolerance is defined as the inability to achieve adequate benefit due to dose-limiting intolerable adverse effects such as parkinsonism, dystonia, akathesia and tardive dyskinesia. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02248035&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=clozapine |
| Invega (paliperidone) |
Not a Benefit |
|
|
| Invega Sustenna (paliperidone palmitate) |
Special Authorization |
For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients: · who are non-adherent to an oral antipsychotic. OR · who are currently receiving a long-acting injectable antipsychotic and require a switch to another injectable. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02354233&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=paliperidone |
| Invega Trinza (paliperidione palmitate) |
Special Authorization
|
For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients: · who are non-adherent to an oral antipsychotic. OR · who are currently receiving a long-acting injectable antipsychotic and require a switch to another injectable. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02455943&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=paliperidone |
| Latuda (lurasidone) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Rexulti (brexpiprazole) |
Open benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Risperdal (risperdone) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Risperdal Consta |
Special Authorization
|
For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients: • who are non-adherent to an oral antipsychotic. OR • who are currently receiving a long-acting injectable antipsychotic and require a switch to another injectable. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02298465&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=risperidone |
| Saphris (asenapine) |
Special Authorization |
For the acute treatment of bipolar disorder as either: • Monotherapy, after inadequate response to a trial of lithium or divalproex sodium, and there is a history of inadequate response, or intolerance to at least one less expensive antipsychotic agent. • Co-therapy with lithium or divalproex sodium, and there is a history of inadequate response or intolerance to at least one less expensive antipsychotic agent. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02374811&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=asenapine |
| Seroquel (quetiapine) |
Open Benefit |
The XR formulation is not a benefit |
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Zeldox (ziprasidone) |
Special Authorization
|
For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients: • with a history of inadequate response or intolerance to at least one less expensive antipsychotic agent OR • who have a contraindication to less expensive options |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02449544&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=ziprasidone |
| Zyprexa (olanzapine) |
Special Authorization |
Schizophrenia and related psychotic disorders: • For the treatment of schizophrenia and related psychotic disorders (not dementia related) in patients with a history of inadequate response or intolerance to at least one less expensive antipsychotic agent OR who have a contraindication to less expensive options. Bipolar Disorder: • Acute: For the treatment of an acute episode of bipolar disorder following inadequate response or intolerance to another atypical antipsychotic. • Maintenance: For maintenance therapy in those patients who have responded to acute treatment with olanzapine following inadequate response or intolerance to another atypical antipsychotic. Coverage will be considered to a MAXIMUM daily dose of 30mg. |
https://www.health.gov.nl.ca/health/prescription/class_search_nl.asp?din=02281821&GReturn=GenericName&Subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&Subtitle2=olanzapine |
| Zyprexa IM (olanzapine IM) |
Not a Benefit |
|
|
| Clopixol (zuclopenthixol) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Fluanxol (flupentixol) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Fluphenazine |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Haldol (haloperidol) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Largactil (chlorpromazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Loxapac/Xylac (loxapine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Majeptil (thioproperazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Navane (thiothixene) |
Open benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Neuleptil (periciazine) |
Open benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Nozinan (methotrimeprazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Orap (pimozide) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Stelazine (trifluoperazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Stemetil (prochlorperazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |
| Trilafon (perphenazine) |
Open Benefit |
|
https://www.health.gov.nl.ca/health/prescription/search_results.asp |